Source: International Congress 2018 – Advances in exercise physiopathology
Disease area: Airway diseases, Pulmonary vascular diseases



Rating:

Share or cite this content

Citations should be made in the following way:
B. Hajian (Antwerp, Belgium), B. Shivalkar (Antwerp, Belgium), F. Ferreira (Kontich, Belgium), C. Van Holsbeke (Kontich, Belgium), W. Voss (Kontich, Belgium), J. De Backer (Kontich, Belgium), P. Fernandes (NJ, United States of America), K. Sartoris (NJ, United States of America), D. Quinn (NJ, United States of America), A. Hufkins (Antwerp, Belgium), P. Parizel (Antwerp, Belgium), J. Cluckers (Antwerp, Belgium), W. De Backer (Antwerp, Belgium). Pulsed inhaled nitric oxide (iNO) improves exercise tolerance and shortness of breath (SOB) in severe COPD subjects with pulmonary hypertension (PH). 5341

Member's Comments

No comment yet.

Related content which might interest you: Nitric oxide and oxygen inhalation during exercise in patients with chronic obstructive lung disease (COPD) and secondary pulmonary hypertension (PH) Source: Eur Respir J 2001; 18: Suppl. 33, 83s Year: 2001 Comparison of hemodynamic effects of inhaled nitric oxide (iNO) and inhaled epoprostenol (iEPO) in patients with pulmonary hypertension (PH) Source: Annual Congress 2011 - Treatment of pulmonary hypertension Year: 2011 Cough sensitivity, airway responsiveness and exhaled nitric oxide (eNO) for predicting the response to bronchodilator therapy (BDT) in patients with chronic non-productive cough Source: Annual Congress 2010 - Cough, airway hyperresponsiveness and asthma control Year: 2010 The effect of inhaled nitric oxide on dyspnea and exercise capacity in mild COPD Source: International Congress 2019 – Exercise physiopathology in various respiratory diseases Year: 2019 Exhaled nitric oxide in obstructive sleep apnea (OSA) patients: short and long term response to automatic positive airway pressure (APAP) therapy Source: Annual Congress 2007 - Metabolic consequences of obstructive sleep apnoea Year: 2007 Is Fractional exhaled nitric oxide (FeNO) test reliable in the differentiation of chronic obstructive pulmonary disease (COPD) and ACOS (asthma-COPD overlap syndrome)? Source: International Congress 2017 – Lung function testing in different patient categories Year: 2017 The influence of short-term therapy of continous positive airway pressure (CPAP) on exhaled nitric oxide concentration (FENO) in patients with obstructive sleep apnea (OSA) Source: Eur Respir J 2005; 26: Suppl. 49, 357s Year: 2005 Predicting performance of cough reflex sensitivity, exhaled nitric oxide (eNO) and bronchial responsiveness for efficacy of bronchodilator therapy on isolated chronic non-productive cough Source: Annual Congress 2011 - Treatment strategies, systemic manifestations and biomarkers in airway diseases Year: 2011 Exhaled nitric oxide in chronic obstructive pulmonary disease: relationship to pulmonary function Source: Eur Respir J 2001; 17: 934-938 Year: 2001 Can fractional exhaled nitric oxide be useful to differentiate asthma-chronic obstructive pulmonary disease (COPD) overlap (ACO) from COPD-only Source: Virtual Congress 2020 – Air pollution and comorbidities Year: 2020 Exercise training and exhaled nitric oxide (eNO) in COPD patients of different severity Source: Eur Respir J 2001; 18: Suppl. 33, 222s Year: 2001 Differential assessment of airway inflammation in chronic obstructive pulmonary disease (COPD) by measurements of exhaled nitric oxide (NO) derived from peripheral vs. central airways Source: Eur Respir J 2003; 22: Suppl. 45, 279s Year: 2003 The acute and chronic effects of dietry nitrate on exercise tolerance in COPD patients Source: International Congress 2015 – Functional capacity, exercise and pulmonary rehabilitation in chronic lung diseases Year: 2015 The acute haemodynamic effects of 'pulsed' inhaled nitric oxide and iv epoprostenol in patients with pulmonary hypertension Source: Eur Respir J 2003; 22: Suppl. 45, 584s Year: 2003 Bronchial nitric oxide is related to symptom relief during fluticasone treatment in COPD Source: Eur Respir J 2010; 35: 72-78 Year: 2010 Predictors of efficacy of bronchodilator therapy for chronic non-productive cough: cough reflex sensitivity, exhaled nitric oxide, bronchial responsiveness? Source: Annual Congress 2008 - Cough and airway hyperresponsiveness Year: 2008 The influence of asthma and COPD exacerbation on exhaled mitric oxide (FENO) Source: Eur Respir J 2004; 24: Suppl. 48, 409s Year: 2004 Inhalation of a prostacyclin analog (iloprost) does not improve exercise capacity in COPD with disproportional pulmonary hypertension Source: Annual Congress 2011 - Pulmonary hypertension in hypoxic lung disease Year: 2011 Decreased plasma levels of nitric oxide (NO) derivatives in obstructive sleep apnea (OSA): response to automatic positive airway pressure (APAP) therapy Source: Eur Respir J 2007; 30: Suppl. 51, 332s Year: 2007 Inhaled nitric oxide (iNO) in patients with acute cor pulmonale due to acute exacerbation of chronic obstructive pulmonary disease (COPD) Source: Eur Respir J 2003; 22: Suppl. 45, 269s Year: 2003